Houston, TX (PRWEB) September 10, 2013
The latest in its ongoing series of scientific meetings on preventive cardiology through screening, early detection and treatment of atherosclerosis, the symposium includes many of the most recognized investigators, clinicians and academicians in the field.
Those presenting and moderating include Dr. PK Shah, Dr. Valentin Fuster, Dr. Lawrence Fine, Dr. Taseem Naqvi, Dr. Daniel Berman, Dr. Jay Cohn and Dr. Morteza Naghavi.
For more information and to register, go to the Society's website: http://www.shapesociety.org or call 713-529-4484.
AGENDA
Saturday, November 16, 2013
2:00 PM (CST) Welcome and Opening Remarks
Morteza Naghavi, M.D., Founder of SHAPE and Executive Chairman of the SHAPE Task Force, Houston, TX
2:10PM Primary Prevention of Atherosclerotic Cardiovascular Disease From Screening
to Vaccination for Atherosclerosis
PK Shah, M.D., Chief, SHAPE Task Force & Scientific Advisory Board;
Professor of Medicine, Director, Division of Cardiology, and Director,
Oppenheimer Atherosclerosis Research Center, Cedars Sinai Medical Center,
UCLA School of Medicine, Los Angeles, CA
2:30PM Update on Noninvasive Imaging of Atherosclerosis and Prophylactic Polypill
Therapy in High Risk Population
Valentin Fuster, M.D., Ph.D., Director of Mount Sinai Heart, the Zena and
Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R.
Kravis Center for Cardiovascular Health, Mount Sinai Medical Center; Professor,
Richard Gorlin, MD and Heart Research Foundation, Mount Sinai School of
Medicine, New York, NY
2:50PM National Institutes of Health’s Initiatives on Primary Prevention of Atherosclerotic
Cardiovascular Disease - Future Directions
Lawrence J. Fine, M.D., Branch Chief, Clinical Applications and Prevention and
Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood
Institute (NHLBI) of the National Institutes of Health (NIH), Bethesda, MD
3:10 - 4:00PM Q&A with Speakers and Discussion Panel
Topic: Primary Prevention of CVD and the Affordable Care Act
Discussion Panel:
Daniel S. Berman, M.D.
Chief of Cardiac Imaging and Nuclear Cardiology; Medical Director of Artificial Intelligence in Medicine Program; Professor of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA
Jay N. Cohn, M.D.
Professor of Medicine, Director, Rasmussen Center for Cardiovascular Disease Prevention,
University of Minnesota, Cardiology Division, Minneapolis, MN
Tasneem Naqvi, M.D.
Director Echocardiography; Senior Associate Consultant, Mayo Clinic, Scottsdale, AZ
Invited Faculty
Arthur Agatston, M.D., Dan Arking, Ph.D., Juan J. Badimon, Ph.D., Raymond D. Bahr, MD
Daniel Berman, M.D., Roger Blumenthal, M.D. Matthew Budoff, M.D., Jay N. Cohn, M.D., Michael Davidson, M.D., James E. Ehrlich, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Zahi A. Fayad, Ph.D., Sergio Fazio, M.D., Ph.D., Steve Feinstein, M.D., Valentin Fuster, M.D., Ph.D., Craig J. Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis A. Kakadiaris, Ph.D., Sanjay Kaul, M.D., M.P.H., Asher Kimchi, MD, Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Naqvi, M.D., Jagat Narula, M.D., Khurram Nasir, M.D., M.P.H., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., John A. Rumberger, Ph.D., M.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee J. Shaw, Ph.D., Henrik Sillesen, M.D., D.MSc., J. David Spence, M.D., H. Robert Superko, M.D., Allen Taylor, M.D., PJ Touboul, M.D
